Compliance Blog
HCCA Complete Healthcare Compliance Manual
The 2023 version is now available. The Complete Healthcare Compliance Manual is an all-in-one, comprehensive guide that provides new and experienced compliance practitioners with guidance and...
Moving the Needle – It’s Time to Rethink the Ethics & Compliance Dialog
Thirty years have passed since ethics and compliance were added to the working vocabulary of life sciences. I know because I was there at the beginning. However, while the business of healthcare...
The Opioid Crisis & the Risk of Diversion
HCCA has just published an updated version of its Complete Healthcare Compliance Manual for 2022. The Complete Healthcare Compliance Manual is an all-in-one, comprehensive guide that provides new...
Mitchell Hamline & MSBA Host CLE Program Tackling the Theranos Case
This CLE program is a collaboration between Mitchell Hamline's Health Law Institute and the Health Law Section of the Minnesota State Bar Association. Dr. Whitelaw and Manny Tzavlakis, Managing...
History of Health Care Compliance – HCCA Podcast
I recently chatted with Adam Turteltaub about the history of health care compliance. Adam is HCCA's Chief Engagement & Strategy Officer. Click the link to check out the podcast: Seth Whitelaw...
Mitchell Hamline Health Law Institute Highlights
So far 2020 has been a great year for Mitchell Hamline's Health Law Institute! Check it out [button link="https://mitchellhamline.edu/health-law-institute/intro/highlights-2020/" color="green"...
Health Care Law & Opioids: How the “Man-Made Plague” Is Transforming the Pharmaceutical Industry (4064)
The current opioid epidemic has been branded as “the worst drug crisis in America’s history” and a “man-made plague.” According to the Centers for Disease Control and Prevention (“CDC”), the current...
Managing Compliance Remotely – Responding to COVID-19
On Monday, April 13, 2020, I will be joining an elite group of fellow panelists to discuss the opportunities and challenges of managing a pharmaceutical or medical device compliance function...
API Manufacturers Beware – New Washington Opioid Lawsuit Targets J&J’s API Business
The epidemic of opioid lawsuits continues to pick-up steam. The latest case is the State of Washington’s latest suit against Johnson & Johnson (“J&J”). It, in part, targets J&J's...